In contrast, BLM transgenic mice expressing human BLM attenuated intestinal tumors when crossed with APC heterozygous mutant mice, thereby indicating that tumor growth can be regulated in a BLM dose-dependent manner (McIlhatton et al., 2015). This evidence concerns the gene BLM and neoplasm.